CLINICAL_TRIALS
trial_result
· 2017-02-17
Clinical Trial Update: Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase II safety and efficacy study of oral ORMD-0801 in type 2 diabetes completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oramed, Ltd. | Conditions: Diabetes Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2017-02-17